Neurological Genetic tests in Dubai & UAE

Compare available Neurological Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Neurological Genetic test prices

Showing 16–30 of 49 matching tests.

Neurological Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5222 DRD2 Gene Sequencing for Myoclonic Dystonia Test This test evaluates the DRD2 gene for pathogenic variants associated with myoclonic dystonia (DYT11).	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in DRD2 gene", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation [] Indications ["Diagnosis of myoclonic dystonia (DYT11)", "Genetic counseling for families with myoclonic dystonia"] Measurement technique Confirm with laboratory Codes LOINC: 50286-7 ICD-10: G24.8, G25.8 Clinical summary This test evaluates the DRD2 gene for pathogenic variants associated with myoclonic dystonia (DYT11).
TEST-4048 EGR2 Gene CMT4E Next‑Generation Sequencing Genetic Test This genetic test identifies pathogenic variants in the EGR2 gene associated with Charcot‑Marie‑Tooth disease type 4E.	Peripheral whole blood, extracted DNA, or FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the EGR2 gene", "Molecular diagnosis of CMT4E"] Parameters [] Preparation ["No fasting required"] Indications ["Suspected Charcot‑Marie‑Tooth disease type 4E", "Genetic counselling for CMT4E", "Family screening for CMT4E"] Measurement technique Confirm with laboratory Codes LOINC: 94409-2 ICD-10: G60.0 Clinical summary This genetic test identifies pathogenic variants in the EGR2 gene associated with Charcot‑Marie‑Tooth disease type 4E.
TEST-4058 FIG4 Gene CMT4J (Charcot-Marie-Tooth Disease Type 4J) Genetic Test This test detects pathogenic variants in the FIG4 gene associated with Charcot-Marie-Tooth disease type 4J.	Whole Blood (EDTA) or Dried Blood Spot (FTA Card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FIG4 gene", "Copy Number Variations (CNV) in the FIG4 gene"] Parameters [] Preparation ["No fasting required", "Continue all prescribed medications"] Indications ["Clinical signs of demyelinating neuropathy", "Family history of CMT", "Consanguineous parents", "Carrier detection in at-risk family members"] Measurement technique Confirm with laboratory Codes LOINC: 21684-6 ICD-10: G60.0 Clinical summary This test detects pathogenic variants in the FIG4 gene associated with Charcot-Marie-Tooth disease type 4J.
TEST-4398 GRIN2A Gene Epilepsy with Neurodevelopmental Defects Genetic Test This genetic test analyzes the GRIN2A gene for pathogenic variants associated with epilepsy and neurodevelopmental defects.	Peripheral whole blood	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GRIN2A gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [] Preparation ["No fasting required", "Signed genetic consent form needed", "Completed clinical questionnaire required"] Indications ["Suspected GRIN2A-related epilepsy-aphasia syndrome", "Neurodevelopmental delay with features suggestive of GRIN2A mutation", "Family history of GRIN2A-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 53429-6 ICD-10: G40.9, F80.0 Clinical summary This genetic test analyzes the GRIN2A gene for pathogenic variants associated with epilepsy and neurodevelopmental defects.
TEST-4469 HOXB1 Gene Facial Paresis Type 3 Genetic Test This test analyzes the HOXB1 gene for pathogenic variants associated with hereditary congenital facial palsy type 3.	Peripheral Whole Blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the HOXB1 gene", "Single-nucleotide variants", "Small insertions/deletions", "Copy number variations"] Parameters [] Preparation ["Mandatory pre-test genetic counselling session.", "Construct a three-generation pedigree chart."] Indications ["Clinical suspicion of hereditary congenital facial palsy type 3", "Family history of congenital facial palsy"] Measurement technique Confirm with laboratory Codes LOINC: 89724-1 ICD-10: Q87.0 Clinical summary This test analyzes the HOXB1 gene for pathogenic variants associated with hereditary congenital facial palsy type 3.
TEST-5629 HSPD1 Gene SPG13 Genetic Test This genetic test identifies pathogenic variants in the HSPD1 gene, confirming a diagnosis of Hereditary Spastic Paraplegia type 13 (SPG13).	Peripheral Whole Blood or DNA FTA Card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the HSPD1 gene", "Full gene coverage including intronic and splice-site regions"] Parameters [] Preparation ["No fasting required unless otherwise specified by your referring physician"] Indications ["Individuals with progressive lower-limb spasticity", "Individuals with gait impairment", "Individuals with a family history suggestive of hereditary spastic paraplegia"] Measurement technique Confirm with laboratory Codes LOINC: 86254-4 ICD-10: G11.4, Z14.8, Z82.79 Clinical summary This genetic test identifies pathogenic variants in the HSPD1 gene, confirming a diagnosis of Hereditary Spastic Paraplegia type 13 (SPG13).
TEST-5743 KIF1A Gene SPG30 Genetic Test This test sequences the entire KIF1A gene to detect mutations associated with hereditary spastic paraplegia type 30 (SPG30). It identifies single nucleotide variants, indels, and c...	Whole Blood (Peripheral)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["KIF1A gene coding region", "Adjacent intronic sequences", "Copy number variations"] Parameters [] Preparation ["No specific fasting required", "Avoid recent blood transfusion (within 4 weeks) unless cleared by physician"] Indications ["Suspected diagnosis of hereditary spastic paraplegia type 30 (SPG30)", "Family history of SPG30", "Neurological evaluation for progressive spasticity"] Measurement technique Confirm with laboratory Codes LOINC: 21634-2 ICD-10: G11.4 Clinical summary This test sequences the entire KIF1A gene to detect mutations associated with hereditary spastic paraplegia type 30 (SPG30). It identifies single nucleotide variants, indels, and copy number changes.
TEST-4064 MFN2 Gene CMT2A2 Next‑Generation Sequencing (NGS) Genetic Test This test identifies pathogenic variants in the MFN2 gene associated with Charcot-Marie-Tooth disease type 2A2.	Whole blood / Extracted DNA / FTA Card	14–21 working days (expedited available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MFN2 gene", "Single nucleotide variants", "Small indels"] Parameters [] Preparation ["No special preparation required", "Ensure hydration", "Inform phlebotomist of bleeding disorders or anticoagulant use"] Indications ["Clinical suspicion of Charcot-Marie-Tooth disease type 2A2", "Family history of CMT2A2", "Need for precise molecular confirmation for targeted screening"] Measurement technique Confirm with laboratory Codes LOINC: 94122-5 ICD-10: G60.0 Clinical summary This test identifies pathogenic variants in the MFN2 gene associated with Charcot-Marie-Tooth disease type 2A2.
TEST-4842 NDE1 Gene Lissencephaly Type 4 with Microcephaly Genetic Test This test identifies mutations in the NDE1 gene associated with lissencephaly type 4 with microcephaly.	Peripheral whole blood (4 mL in EDTA tube) or extracted genomic DNA	3–4 weeks (expedited 2–3 weeks available for urgent cases)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Mutations in the NDE1 gene", "Point mutations", "Small deletions/insertions", "Copy number variations"] Parameters [] Preparation ["No specific patient preparation required"] Indications ["Clinical suspicion of lissencephaly type 4 with microcephaly", "Family history of lissencephaly type 4 with microcephaly", "Need for genetic confirmation", "Recurrence risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 100116-6 ICD-10: Q04.3, Q02, Z15.81 Clinical summary This test identifies mutations in the NDE1 gene associated with lissencephaly type 4 with microcephaly.
TEST-4720 NDUFAF3 Gene Leigh Syndrome Genetic Test This test identifies pathogenic variants in the NDUFAF3 gene, which are associated with Leigh syndrome, a severe inherited mitochondrial neurological disorder.	Whole blood (3–5 mL in EDTA tube), dried blood spot on FTA card, or previously extracted DNA	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the NDUFAF3 gene", "Carrier status for NDUFAF3 variants"] Parameters [] Preparation ["No special preparation such as fasting is required.", "A mandatory pre-test genetic counselling session must be completed."] Indications ["Suspected diagnosis of Leigh syndrome", "Family history of Leigh syndrome", "Carrier screening for NDUFAF3 variants"] Measurement technique Confirm with laboratory Codes LOINC: 94038-6 ICD-10: G31.82 Clinical summary This test identifies pathogenic variants in the NDUFAF3 gene, which are associated with Leigh syndrome, a severe inherited mitochondrial neurological disorder.
TEST-4638 NDUFS4 Gene Leigh Syndrome Genetic Test This test identifies pathogenic variants in the NDUFS4 gene, a nuclear-encoded cause of Leigh syndrome.	Peripheral Whole Blood (EDTA), Extracted DNA, or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in NDUFS4 gene", "Mitochondrial complex I function"] Parameters [] Preparation ["Inform doctor of all supplements, vitamins, and cofactors", "Do not discontinue prescribed medication without consulting physician"] Indications ["Suspected Leigh syndrome", "Family history of Leigh syndrome", "Need for accurate recurrence risk counselling"] Measurement technique Confirm with laboratory Codes LOINC: 82566-0 ICD-10: G31.82 Clinical summary This test identifies pathogenic variants in the NDUFS4 gene, a nuclear-encoded cause of Leigh syndrome.
TEST-4728 NDUFS7 Gene (Leigh Syndrome) Genetic Testing via NGS Test This test identifies pathogenic variants in the NDUFS7 gene associated with Leigh syndrome using Next-Generation Sequencing.	Whole blood (peripheral venous) or extracted DNA	21–28 Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["NDUFS7 gene sequence variants", "Pathogenic mutations"] Parameters [] Preparation ["No fasting required", "Bring previous medical reports", "List of current medications"] Indications ["Suspected Leigh syndrome", "Family history of Leigh syndrome", "Carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 81269-8 ICD-10: G31.82 Clinical summary This test identifies pathogenic variants in the NDUFS7 gene associated with Leigh syndrome using Next-Generation Sequencing.
TEST-5329 NGEF Gene Neurodevelopmental Disorder Genetic Test This genetic test screens for pathogenic variants in the NGEF gene linked to neurodevelopmental disorders.	Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the NGEF gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication"] Indications ["Suspected NGEF-related neurodevelopmental disorder", "Establishing a molecular diagnosis for neurodevelopmental conditions"] Measurement technique Confirm with laboratory Codes LOINC: 89578-0 ICD-10: Z13.21 Clinical summary This genetic test screens for pathogenic variants in the NGEF gene linked to neurodevelopmental disorders.
TEST-5523 PINK1 Gene (PARK6) Parkinson Genetic Test This test evaluates the PINK1 gene for mutations associated with early-onset Parkinson's disease.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PINK1 gene sequence", "Copy Number Variations (CNV) in PINK1 gene"] Parameters [] Preparation ["No specific fasting required", "No need to stop prescribed medications unless advised by your doctor"] Indications ["Diagnosis of autosomal recessive early-onset Parkinson's disease", "Carrier screening in families with known PINK1 mutations"] Measurement technique Confirm with laboratory Codes LOINC: 82321-0 ICD-10: G20 Clinical summary This test evaluates the PINK1 gene for mutations associated with early-onset Parkinson's disease.
TEST-4144 PRRT2 Gene Sequencing Test for Familial Infantile Convulsions with Paroxysmal Choreoathetosis (NGS) This test identifies mutations in the PRRT2 gene associated with specific neurological disorders.	Peripheral Blood	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PRRT2 gene mutations", "Full gene coverage"] Parameters [] Preparation [] Indications ["Clinical suspicion of a PRRT2-related disorder", "Prior genetic counseling"] Measurement technique Confirm with laboratory Codes LOINC: 81607-8 ICD-10: G40.309, G25.5 Clinical summary This test identifies mutations in the PRRT2 gene associated with specific neurological disorders.

Category overview

Neurological Genetic: overview

Pinpointing the exact hereditary cause of a progressive movement disorder, severe neuropathy, or early-onset cognitive decline is essential for unlocking the most effective neurological care available. As a highly focused diagnostic tool in our Molecular Genetics department, Neurological Genetic testing specifically targets the exact DNA mutations responsible for your family's unique neurological challenges. By leveraging advanced sequencing technology, this precise genomic screening confirms conditions like inherited ataxias or early-onset Alzheimer's, providing the critical data necessary to assess carrier status, evaluate risks for future children, and safely guide tailored neurological interventions. Highly regarded for specialized diagnostic excellence among the best diagnostic labs in the UAE, DNA Labs guarantees strict patient confidentiality, exceptional analytical precision, and remarkably fast turnaround times. Take control of your long-term brain health—schedule your neurological genetic testing in UAE, coordinate a comfortable home sample collection, or consult our expert medical professionals.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.